Veru (VERU) Operating Leases (2019 - 2026)
Veru (VERU) posted quarterly Operating Leases of $2.1 million for Q1 2026, down 21.88% year-over-year from $2.6 million in Q1 2025, and down 6.76% quarter-over-quarter from $2.2 million in Q4 2025.
Veru (VERU) Operating Leases (2019 - 2026) Analysis & Trends
Veru (VERU) has reported Operating Leases for 8 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 21.88% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 21.88% YoY), while the FY2025 annual figure was $2.4 million, down 18.84% from the prior year.
- Operating Leases eased to $2.1 million in Q1 2026 per VERU's latest filing, from $2.2 million in the prior quarter.
- Across five years, Operating Leases topped out at $5.3 million in Q1 2022 and bottomed at $2.1 million in Q1 2026.
- Historically, Operating Leases has averaged $3.3 million across 5 years, with a median of $3.3 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Leases jumped 658.2% — and 2023, when it retreated 24.53%.
- Veru's Operating Leases stood at $4.0 million in 2022, then slipped by 12.79% to $3.5 million in 2023, then decreased by 19.71% to $2.8 million in 2024, then dropped by 20.27% to $2.2 million in 2025, then slipped by 6.76% to $2.1 million in 2026.
- Business Quant data shows VERU's Operating Leases at $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.78 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 3.81 Mn |
| Mar 31, 2023 | 3.99 Mn |
| Dec 31, 2022 | 3.96 Mn |
| Sep 30, 2022 | 4.09 Mn |
| Jun 30, 2022 | 4.26 Mn |
| Mar 31, 2022 | 5.28 Mn |
| Dec 31, 2021 | 522,709.00 |
| Sep 30, 2021 | 609,921.00 |